skip to primary navigationskip to content

Cambridge Infectious Diseases

An Interdisciplinary Research Centre at the University of Cambridge

Studying at Cambridge

 

Industry Partnership

Connect with infectious diseases researchers to develop disruptive interdisciplinary research

Cambridge Infectious Diseases IRC represents the majority of Cambridge University researchers developing new infectious diseases surveillance, prediction, prevention, diagnostic and therapeutic technologies, improving global control capabilities and applying systems approaches across a wide range of  infectious diseases challenges. CID IRC provides a portal for industry to interact with infectious diseases researchers - from social scientists, to mathematical modellers to chemists to medics to vets to engineers to architects - at the University and affiliated institutes in the Cambridge cluster.

  • help finding the right academic contact to work with industry,
  • facilitate collaborations between industry and Cambridge University,
  • run innovation competitions to carry out small scale feasibility studies,
  • run workshops on specific infectious diseases themes.

One of the strategic aims of Cambridge Infectious Diseases IRC is is to facilitate collaborations, which might include

  • long-term academic research industry relationships,
  • student placements,
  • PhD studentships,
  • consultancy.

We are not prescriptive about the nature of any collaborations and work in connection with many other networks and groups facilitating business partnerships. However, we specialise in interfacing at the edge of disciplinary boundaries. 

Contact

Please contact the CID Coordinator Dr Allyson Walsh if you would like to discuss potential collaborations/projects.

Engaging with the wider University

If you like to find out more generally how Cambridge University engages with industry, policy makers, NGOs and philanthropists please visit its "For businesses" section on its website.

 

Industry Partnerships

Advancing disease understanding and drug discovery in infectious diseases: Collaboration between Shionogi and Department of Biochemistry, University of Cambridge

Improving the therapeutic potential of antibody-mediated inhibition of Pseudomonas aeruginosa.

Read More  Industry Partnerships - Therapeutics